UNSPSC 51182047: Tibolone

This classification denotes an anabolic steroid with the molecular formula C21H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FF9X0205V2, chemically known as 19-norpregn-5(10)-en-20-yn-3-one, 17-hydroxy-7-methyl-, (7alpha,17alpha)- but generally known as tibolone, which bears US NIH Compound Identifier 21844. European Medicines Agency schedules Tibolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11022MIG.

UNSPSC 51182047 Tibolone is a Commodity code that does not show relevant recent state and local procurement activity. The code addresses a pharmaceutical active ingredient—a synthetic steroid used in hormone replacement therapy—that state and local governments do not directly procure through public solicitations. State and local health agencies, school districts, municipalities, and other jurisdictions do not issue RFPs, RFQs, IBFs, or ITBs for raw pharmaceutical compounds; instead, they procure finished pharmaceutical products (tablets, injectables, transdermal patches) through group purchasing organizations, formulary management systems, or pharmacy benefit managers, which fall under different UNSPSC families such as medicinal chemicals and botanical products or finished-goods pharmaceuticals. The code's placement in the pharmaceutical ingredients taxonomy reflects manufacturing and wholesale supply-chain classification rather than the procurement patterns of state and local government.

No recent state and local opportunities were identified under this code. If your firm supplies tibolone as a raw material or active pharmaceutical ingredient to manufacturers or wholesalers serving state Medicaid programs or public health systems, evaluate opportunities through federal pharmaceutical procurement channels (VA, DoD, Indian Health Service) or direct commercial relationships with licensed pharmaceutical manufacturers and distributors rather than through state and local government RFPs and RFQs.